Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Characterizing the functional relevance of neuronal PAS domain-containing protein 4 (NPAS4) to inflammatory and neurodegenerative processes in models of multiple sclerosis
FY 2018-19
Summary
Multiple sclerosis (MS) is the leading neurological disease in young adults in Canada, and it is second only to trauma as the most disabling. MS is a neurodegenerative disease where immune cells attacks myelin that protects nerve cells in the brain and spinal cord. This damages their ability to send information and results in nerve cell loss. MS causes disabling symptoms including vision loss, muscle weakness or paralysis, and problems with thinking and memory. Current MS drugs help people with relapsing MS where disease changes between attacks and recovery, but they do not treat progressive MS where disability worsens significantly. This drives the need to identify pathways that not only limit immune attack but also protect against neurodegeneration. Our laboratory found that levels of neuronal PAS domain-containing protein 4 (NPAS4), a key protein in nerve cell health and signaling, changes over time in a mouse model of MS. Importantly, deleting Npas4 protects against disability. Npas4 also directs other genes, many of which remain to be identified. Our project will study the role of Npas4 in disease development and nerve cell protection. Npas4 will be measured in MS mouse models at each disease stage – onset, progression, and recovery. We will identify immune cells and their products that regulate Npas4 and test how deleting or over producing Npas4 impacts nerve cell survival in a culture dish. We will also delete Npas4 during disease development in the MS mouse model to see when it is most important. Overall, this project will give valuable insight into the role of Npas4 as a regulator of neurodegeneration and disability. The goal is to use these findings to identify Npas4-mediated neuroprotective factors that may be targeted to limit disability for people with MS.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
415333
Name
Kamma Emily
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing the functional relevance of neuronal PAS domain-containing protein 4 (NPAS4) to inflammatory and neurodegenerative processes in models of multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Animal Models; Autoimmunity; Central Nervous System Inflammatory Disease; Multiple Sclerosis; Neurodegeneration; Neuroimmunology; Neuroinflammation; Neuropathology; Neuroprotection
Abstract
Multiple sclerosis (MS) is the leading neurological disease in young adults in Canada, and it is second only to trauma as the most disabling. MS is a neurodegenerative disease where immune cells attacks myelin that protects nerve cells in the brain and spinal cord. This damages their ability to send information and results in nerve cell loss. MS causes disabling symptoms including vision loss, muscle weakness or paralysis, and problems with thinking and memory. Current MS drugs help people with relapsing MS where disease changes between attacks and recovery, but they do not treat progressive MS where disability worsens significantly. This drives the need to identify pathways that not only limit immune attack but also protect against neurodegeneration. Our laboratory found that levels of neuronal PAS domain-containing protein 4 (NPAS4), a key protein in nerve cell health and signaling, changes over time in a mouse model of MS. Importantly, deleting Npas4 protects against disability. Npas4 also directs other genes, many of which remain to be identified. Our project will study the role of Npas4 in disease development and nerve cell protection. Npas4 will be measured in MS mouse models at each disease stage – onset, progression, and recovery. We will identify immune cells and their products that regulate Npas4 and test how deleting or over producing Npas4 impacts nerve cell survival in a culture dish. We will also delete Npas4 during disease development in the MS mouse model to see when it is most important. Overall, this project will give valuable insight into the role of Npas4 as a regulator of neurodegeneration and disability. The goal is to use these findings to identify Npas4-mediated neuroprotective factors that may be targeted to limit disability for people with MS.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kamma, Emily
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~